Evolution of the Average Target: Ipsen

Evolution of the Target Price: Ipsen

Changes in Analyst Recommendations: Ipsen

84d9bbfcfe9489a1006949bd7d.2VGHJKelrgZ1nrvtFwWOko68cYYbfLnQITTiHlH5Dac.qBveF5DwlzY7_8irUXbY8731J-MsCt22E3WPTzCLfPSyYcBSyJHqRCPNyA~fc07eec3dbfbf19962033e6c44d1b000
18/09 AlphaValue/Baader Europe Ups Price Target, Forecasts for Ipsen on 'Solid' H1 Performance MT
17/09 Ipsen: Incorporating solid H1 operational performance + guidance upgrade Alphavalue
17/09 Ipsen extends its pullback despite AlphaValue Zonebourse
20/08 Cancer vaccines finally garner the spotlight Alphavalue
17/08 Kepler Cheuvreux Boosts Ipsen PT, Maintains Hold Rating MT
03/08 Jefferies Downgrades Ipsen to Underperform, Boosts PT MT
30/07 Ipsen: Another quarterly beat; 2026 guidance upgraded Alphavalue
14/07 Where would AI lead Pharma in the long run? Alphavalue
07/07 AlphaValue/Baader Europe Cuts Ipsen Price Target Amid Future Patent Expiries, Mid-term Risks MT
06/07 Ipsen: Reassessing mid-term risks Alphavalue
01/07 AlphaValue/Baader Europe Downgrades Ipsen to Add, Lifts PT MT
01/07 Oddo BHF still neutral on Ipsen after a new acquisition Zonebourse
30/06 Ipsen Extends Its Rally, Backed by Oddo BHF Zonebourse
05/06 HC Wainwright Starts Ipsen Coverage with Buy Rating MT
28/05 Ipsen Price Target, Estimates Up as AlphaValue/Baader Europe Notes Upcoming Data Readouts, Product Mix MT
27/05 Ipsen: Beneficiary of favourable product mix and imminent readouts Alphavalue
24/04 Profit-taking hits Ipsen despite UBS price target hike Zonebourse
24/04 Ipsen: Opened the year with encouraging traction Alphavalue
14/04 Deutsche Bank raises price target on Ipsen Zonebourse
16/03 BNP Paribas Upgrades Ipsen to Neutral, Boosts PT MT
10/03 CIC Corporate & Institutional Banking Upgrades Ipsen to Buy, Boosts PT MT
13/02 Ipsen Remains in the Green with UBS Support Zonebourse
12/02 Ipsen: Markets applaud strong finish to 2025 and better-than-expected 2026 outlook Alphavalue
14/01 Ipsen, Top Gainer on the SBF 120 and SRD at Wednesday, January 14, 2026 Close Zonebourse
14/01 Ipsen and EMS-Chemie Shine on the Stock Market, Vistry and Pearson Struggle Zonebourse

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+12.13%
+15.15%
+3.25%
+5.1%
+3.34%
+6.94%
- +28.29%
-4.15%
+4.81%
+21.93%
Average +9.68%
Weighted average by Cap. +9.47%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
148.10EUR
Average target price
166.07EUR
Spread / Average Target
+12.13%
High Price Target
235.00EUR
Spread / Highest target
+58.68%
Low Price Target
130.00EUR
Spread / Lowest Target
-12.22%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
AA